Skip to content

    Camlin Fine

    CAMLINFINEMixed
    Chemicals·8 Aug 2025
    Management Summary

    Camlin Fine Sciences reported a challenging Q1 FY26 with revenue slightly down to INR423 crores and EBITDA at INR19 crores, impacted by significant one-off costs from annual plant maintenance shutdowns and employee bonuses. Despite these headwinds, the high-growth Blends business continued its strong performance, while the Vanillin segment maintained stable volumes amidst channel stock clearance and evolving tariff dynamics. Management expects a rebound as one-off impacts subside and channel inventories normalize.

    Highlights

    8

    • Revenue for Q1 FY26 stood at INR423 crores, a slight decrease from INR437 crores in Q1 FY25.

    • EBITDA was INR19 crores, resulting in an EBITDA margin of 4.5% for the quarter.

    • The quarter was impacted by one-off costs including INR12.5 crores unabsorbed fixed costs due to plant shutdowns, INR7.5 crores for one-time employee bonuses, and INR7-8 crores in margin loss from plant start-up consumption.

    • Gross margins reduced from 48% to 44% primarily due to lower production, with sustainable gross margins expected to be 40-45%.

    • The Blends business demonstrated strong growth across geographies, with Mexico achieving 17%+ EBITDA margins and North America at 10-12%.

    • Vanillin business saw a small dip in revenue (INR5 crores) but maintained stable volumes, operating at 50% capacity utilization in Q1, now at 60%.

    • Vanillin average realization in Q1 was $12.5, with current US retail prices at $18-19 and European prices at $14-15.

    • Channel stocks in the US and Europe are expected to clear out in the next 3-4 months.

    Concerns

    1

    • Uncertainty and volatility of US tariffs on Indian vanillin

    What Changed3

    vs Q2 FY26

    Tone shiftGood → MixedGuidance items12 → 10 (-2)Risks discussed6 → 4 (-2)

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹423 Cr-3.2%YoY
    2. 02EBITDA₹19 Cr
    3. 03EBITDA Margin4.5%
    4. 04Gross Margin44%

    Segment breakdown

    Blends Business
    35% Overall Gross Margin50 Mn Mexico Revenue (FY26)17% Mexico EBITDA Margin30 Mn North America Revenue (FY26)10% North America EBITDA Margin25 Mn Brazil Revenue (FY26)10% Brazil EBITDA Margin15 Mn CFS Vitafor Revenue (FY26)5% CFS Vitafor EBITDA Margin
    Vanillin Business
    50% Q1 Capacity Utilization60% Current Capacity Utilization12.5 USD/kg Q1 Average Realization18 USD/kg Current US Retail Price14 USD/kg Current Europe Price7.5 USD/kg Current China Price9.25 USD/kg Production Cost (60% Util)540 tons Q1 Third-Party Sales Volume
    Straights Business
    40% Hydroquinone Gross Margin20% Catechol Gross Margin
    List

    Guidance & targets

    10
    CategoryTargetPriority
    Profitability
    Sustainable Gross Margin
    40-45%
    		Medium
    Profitability
    China Business Losses
    Zero
    		High
    Volume
    Vanillin Annual Sales Volume
    2,500-3,000 tons
    		High
    Realization
    Vanillin Average Realization
    $13-14
    		Medium
    Growth
    Blends Business Growth
    20%
    		High
    Capacity
    Vanillin Capacity Utilization
    70-80%
    		Medium
    Capacity
    Vanillin Capacity Utilization
    Full capacity
    		Medium
    Inventory
    Channel Stock Clearance (US & Europe)
    3-4 months
    		Medium
    Cost
    Europe Site Cost
    INR2 crores/quarter
    		High
    Cost
    Europe Site Cost
    INR5 crores/quarter
    		High

    Risks & concerns

    6
    RiskSeverity

    Channel stock overhang in US and Europe for vanillin

    Observing channel stocks in main geographies (Europe and US) where antidumping duty is present, impacting average realization. — Management acknowledged

    medium

    Uncertainty and volatility of US tariffs on Indian vanillin

    Current US tariff is 50% and is a moving target; management notes it's unprecedented and difficult to predict future changes (e.g., could go to 150%). — Management acknowledged

    high

    Sluggish demand and Chinese competition globally

    There is sluggish demand and Chinese issues all over the world, with Trump tariffs also being a watch item. — Management acknowledged

    medium

    Potential for Chinese competitors to enter market if prices are too high

    If vanillin prices (including tariffs) become too high, it could make it viable for Chinese competitors (with 280% duty) to re-enter the market. — Management acknowledged

    medium

    Areas of Evasion(2)

    • exact future movement of US tariffs
    • Solvay's production cost

    Q&A highlights

    3

    “We had unabsorbed fixed of about INR12.5 crores in all our plants in the month of April and around INR7.5 crores was paid for one-time bonus to the employees of Blends. Apart from this, there was no as I said, we also had 2% to 3% of margin loss because of start-up of plants. We had closed the plants. We started the plants. The first dosing, the consumption increases. That will be around 2% to 3%, that will be another INR7 crores to INR8 crores.”

    Provides clear quantification of the temporary factors that suppressed Q1 profitability, allowing investors to adjust their view of underlying performance.

    asked by Raman KV

    3 min read6 chapters

    Detailed Narrative

    01

    Q1 FY26 Performance and One-off Impacts

    Camlin Fine Sciences reported a Q1 FY26 revenue of INR423 crores, a slight decline from INR437 crores in the prior year. EBITDA for the quarter was INR19 crores, translating to an EBITDA margin of 4.5%. This performance was significantly impacted by several one-off📎 events: INR12.5 crores in unabsorbed fixed costs due to annual maintenance shutdowns at Dahej and Tarapur facilities in April, INR7.5 crores for one-time📎 performance bonuses to Blends business employees, and an additional INR7-8 crores in margin loss from higher consumption during plant start-ups. These factors collectively suppressed the quarter's profitability.

    02

    Blends Business: Strong Growth and Evolving Margins

    The Blends business continued its strong growth trajectory across all geographies, with management confirming a 20% growth target remains intact. EBITDA margins vary by maturity: Mexico, a mature market, boasts 17%+ margins, while North America is at 10-12% (expected to reach high-teen next year). Growing regions like India, Europe, and Vitafor (expected $15-16 million revenue this year) currently have margins in the 8-10% range. The overall blended gross margin for this segment is typically 35-40%, with management investing in sales teams to drive future growth.

    03

    Vanillin Business: Tariff Challenges and Capacity Utilization

    The Vanillin business experienced a small revenue dip of INR5 crores but maintained stable volumes. Capacity utilization in Q1 was around 50% due to plant shutdowns, currently running at 60%. Management aims for 70-80% utilization by FY27 and full capacity by FY28. Average realization in Q1 was $12.5/kg, with current US retail prices at $18-19/kg and European prices at $14-15/kg. The US market faces a 50% tariff on Indian vanillin, but Camlin remains competitive due to significantly higher antidumping duties (280%) on Chinese producers.

    04

    Gross Margin Outlook and Segment Profitability

    Overall gross margins for the company decreased from 48% to 44% in Q1 FY26, primarily due to lower production volumes. Management expects sustainable gross margins to be in the 40-45% range going forward⏳. Within the Straights business, the hydroquinone chain typically yields gross margins closer to 50%, while the catechol chain is around 20%. The Blends business maintains a gross margin of 35-40%.

    05

    Market Strategy and Inventory Clearance

    Camlin Fine Sciences is closely monitoring channel stocks in Europe and the US, which are expected to clear within the next 3-4 months. New contracts for vanillin are typically finalized in October-November for January delivery. The company aims for an annual vanillin sales volume of 2,500-3,000 tons, with a target mix of 40% to Europe, 30-40% to the US, and the balance to the rest of the world. Despite tariff uncertainties, the strategy is to maintain a presence in both key geographies to service multinational customers.

    06

    China and Europe Business Outlook

    Management expects losses from the China business to be eliminated by the end of FY26. For the mothballed Europe site, the cost is estimated to be around INR5 crores per quarter for the current financial year, reducing to approximately INR2 crores per quarter in the next financial year. The company is focusing on high-purity, high-quality vanillin for high value-added F&B products in markets where Chinese players might challenge on price.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.